{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T23:47:14Z","timestamp":1782085634814,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006387","name":"Fondation Leenaards","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013788","name":"Facult\u00e9 des Sciences et de M\u00e9decine, Universit\u00e9 de Fribourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013788","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"DOI":"10.1038\/s41533-026-00499-1","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:18:24Z","timestamp":1776752304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pelargonium sidoides extract (EPs\u00ae 7630) versus usual care for acute bronchitis in Swiss primary care (PHYTOBRONCH): a pragmatic, open-label, randomised controlled trial"],"prefix":"10.1038","volume":"36","author":[{"given":"Ang\u00e9lique","family":"Bourqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane","family":"Corpataux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bonofiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Baggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Csajka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Rodondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Podmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"499_CR1","first-page":"214","volume":"111","author":"E Mulhem","year":"2025","unstructured":"Mulhem, E., Patalinghug, E. & Eraqi, H. Acute bronchitis: Rapid evidence review. Am Fam Physician 111, 214\u2013217 (2025).","journal-title":"Am Fam Physician"},{"key":"499_CR2","unstructured":"Office f\u00e9d\u00e9ral de la sant\u00e9 publique. Jahresbericht zu den respiratorischen Viren 2024\/2025. Berne: OFSP; 2025."},{"key":"499_CR3","first-page":"CD000245","volume":"6","author":"SM Smith","year":"2014","unstructured":"Smith, S. M., Fahey, T., Smucny, J. & Becker, L. A. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 6, CD000245 (2014).","journal-title":"Cochrane Database Syst Rev"},{"key":"499_CR4","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1093\/jac\/dkx278","volume":"72","author":"D Glinz","year":"2017","unstructured":"Glinz, D. et al. Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide survey. J Antimicrob Chemother 72, 3205\u20133212 (2017).","journal-title":"J Antimicrob Chemother"},{"key":"499_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629\u2013655 (2022).","journal-title":"Lancet"},{"key":"499_CR6","volume":"2014","author":"SM Smith","year":"2014","unstructured":"Smith, S. M., Schroeder, K. & Fahey, T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev 2014, CD001831 (2014).","journal-title":"Cochrane Database Syst Rev"},{"key":"499_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.anorl.2014.11.001","volume":"132","author":"O Laccourreye","year":"2015","unstructured":"Laccourreye, O. et al. Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants. Eur Ann Otorhinolaryngol Head Neck Dis 132, 31\u201334 (2015).","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"499_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/fampra\/cmac112","volume":"40","author":"C Llor","year":"2023","unstructured":"Llor, C. et al. Effectiveness of antitussives, anticholinergics, and honey versus usual care in adults with uncomplicated acute bronchitis: a multiarm randomized clinical trial. Fam Pract 40, 407\u2013413 (2023).","journal-title":"Fam Pract"},{"key":"499_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.581840","volume":"11","author":"D Silveira","year":"2020","unstructured":"Silveira, D. et al. COVID-19: is there evidence for the use of herbal medicines as adjuvant symptomatic therapy?. Front Pharmacol 11, 581840 (2020).","journal-title":"Front Pharmacol"},{"key":"499_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.phymed.2006.11.030","volume":"14","author":"S Bladt","year":"2007","unstructured":"Bladt, S. & Wagner, H. From the Zulu medicine to the European phytomedicine Umckaloabo. Phytomedicine 14, 2\u20134 (2007).","journal-title":"Phytomedicine"},{"key":"499_CR11","unstructured":"The Scientific Foundation for Herbal Medicinal Products. Pelargonii radix. 2 ed. ESCOP Monographs. 2015."},{"key":"499_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jep.2014.01.009","volume":"152","author":"M Moyo","year":"2014","unstructured":"Moyo, M. & Van Staden, J. Medicinal properties and conservation of Pelargonium sidoides DC. J Ethnopharmacol 152, 243\u2013255 (2014).","journal-title":"J Ethnopharmacol"},{"key":"499_CR13","volume":"2013","author":"A Timmer","year":"2013","unstructured":"Timmer, A. et al. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev 2013, CD006323 (2013).","journal-title":"Cochrane Database Syst Rev"},{"key":"499_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.explore.2005.08.009","volume":"1","author":"AG Chuchalin","year":"2005","unstructured":"Chuchalin, A. G., Berman, B. & Lehmacher, W. Treatment of acute bronchitis in adults with a Pelargonium Sidoides preparation (EPs\u00ae 7630): a randomized, double-blind, placebo-controlled trial. Explore 1, 437\u2013445 (2005).","journal-title":"Explore"},{"key":"499_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1055\/s-2008-1074519","volume":"74","author":"H Matthys","year":"2008","unstructured":"Matthys, H. & Funk, P. EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial. Planta Med 74, 686\u2013692 (2008).","journal-title":"Planta Med"},{"key":"499_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1185\/03007991003798463","volume":"26","author":"H Matthys","year":"2010","unstructured":"Matthys, H., Lizogub, V. G., Malek, F. A. & Kieser, M. Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides. Curr Med Res Opin 26, 1413\u20131422 (2010).","journal-title":"Curr Med Res Opin"},{"key":"499_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1078\/1433-187X-00308","volume":"10","author":"H Matthys","year":"2003","unstructured":"Matthys, H., Eisebitt, R., Seith, B. & Heger, M. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine 10, 7\u201317 (2003).","journal-title":"Phytomedicine"},{"key":"499_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1335309","volume":"15","author":"FA Malek","year":"2024","unstructured":"Malek, F. A. & Funk, P. Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data. Front Pharmacol 15, 1335309 (2024).","journal-title":"Front Pharmacol"},{"key":"499_CR19","unstructured":"European medicines Agency. Assessment report on Pelargonium sidoides DC and\/or Pelargonium reniforme Curt., radix. EMA\/HMPC\/444244\/2015 (2018)."},{"key":"499_CR20","first-page":"1253","volume":"11","author":"C Mwachari","year":"2007","unstructured":"Mwachari, C. et al. Validation of a new clinical scoring system for acute bronchitis. Int J Tuberc Lung Dis 11, 1253\u20131259 (2007).","journal-title":"Int J Tuberc Lung Dis"},{"key":"499_CR21","doi-asserted-by":"publisher","first-page":"e210369","DOI":"10.1001\/jamanetworkopen.2021.0369","volume":"4","author":"S Thomas","year":"2021","unstructured":"Thomas, S. et al. Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: The COVID A to Z randomized clinical trial. JAMA Netw Open 4, e210369 (2021).","journal-title":"JAMA Netw Open"},{"key":"499_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.arbres.2012.02.006","volume":"48","author":"A Moragas","year":"2012","unstructured":"Moragas, A., Llor, C., Gabarr\u00fas, A. & Miravitlles, M. Reliability of a self-administered diary of symptoms for assessing the evolution of acute bronchitis. Arch Bronconeumol 48, 261\u2013262 (2012).","journal-title":"Arch Bronconeumol"},{"key":"499_CR23","unstructured":"European Medicines Agency. ICH E2A Clinical safety data management: definitions and standards for expedited reporting - Scientific guideline. CPMP\/ICH\/377\/95 (1995)."},{"key":"499_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12890-019-0898-3","volume":"19","author":"L Lhopitallier","year":"2019","unstructured":"Lhopitallier, L. et al. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial. BMC Pulm Med 19, 143 (2019).","journal-title":"BMC Pulm Med"},{"key":"499_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-STS313","volume":"25","author":"EA Stuart","year":"2010","unstructured":"Stuart, E. A. Matching methods for causal inference: A review and a look forward. Stat Sci 25, 1\u201321 (2010).","journal-title":"Stat Sci"},{"key":"499_CR26","volume-title":"Rev. ed.","author":"J Cohen","year":"1988","unstructured":"Cohen, J. Statistical Power Analysis for the Behavioral Sciences. Rev. ed. Lawrence Erlbaum Associates: New York, 1988). ed."},{"key":"499_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.31887\/DCNS.2011.13.2\/hmoeller","volume":"13","author":"HJ M\u00f6ller","year":"2011","unstructured":"M\u00f6ller, H. J. Effectiveness studies: advantages and disadvantages. Dialogues Clin Neurosci 13, 199\u2013207 (2011).","journal-title":"Dialogues Clin Neurosci"},{"key":"499_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMoa1608033","volume":"375","author":"J Vestbo","year":"2016","unstructured":"Vestbo, J. et al. Effectiveness of fluticasone furoate\u2013vilanterol for COPD in clinical practice. N Engl J Med 375, 1253\u20131260 (2016).","journal-title":"N Engl J Med"},{"key":"499_CR29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jama.2016.0275","volume":"315","author":"D Meeker","year":"2016","unstructured":"Meeker, D. et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA 315, 562\u2013570 (2016).","journal-title":"JAMA"},{"key":"499_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/bmjqs.2010.049049","volume":"20","author":"N Adriaenssens","year":"2011","unstructured":"Adriaenssens, N. et al. European surveillance of antimicrobial consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf 20, 764 (2011).","journal-title":"BMJ Qual Saf"},{"key":"499_CR31","doi-asserted-by":"publisher","first-page":"ii11","DOI":"10.1093\/jac\/dkx503","volume":"73","author":"DRM Smith","year":"2018","unstructured":"Smith, D. R. M. et al. Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care. J Antimicrob Chemother 73, ii11\u2013ii18 (2018).","journal-title":"J Antimicrob Chemother"},{"key":"499_CR32","first-page":"401","volume":"32","author":"ARJ Dekker","year":"2015","unstructured":"Dekker, A. R. J., Verheij, T. J. M. & van der Velden, A. W. Inappropriate antibiotic prescription for respiratory tract indications: most prominent in adult patients. Fam Pract 32, 401\u2013407 (2015).","journal-title":"Fam Pract"},{"key":"499_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1397096","volume":"12","author":"C Llor","year":"2024","unstructured":"Llor, C. et al. C-reactive protein point-of-care testing in primary care-broader implementation needed to combat antimicrobial resistance. Front Public Health 12, 1397096 (2024).","journal-title":"Front Public Health"},{"key":"499_CR34","first-page":"CD004417","volume":"10","author":"GKP Spurling","year":"2023","unstructured":"Spurling, G. K. P., Dooley, L., Clark, J. & Askew, D. A. Immediate versus delayed versus no antibiotics for respiratory infections. Cochrane Database of Systematic Reviews 10, CD004417 (2023).","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"499_CR35","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S1473-3099(23)00125-1","volume":"23","author":"NTT Do","year":"2023","unstructured":"Do, N. T. T. et al. Implementation of point-of-care testing of C-reactive protein concentrations to improve antibiotic targeting in respiratory illness in Vietnamese primary care: a pragmatic cluster-randomised controlled trial. Lancet Infect Dis 23, 1085\u20131094 (2023).","journal-title":"Lancet Infect Dis"},{"key":"499_CR36","doi-asserted-by":"publisher","first-page":"e025396","DOI":"10.1136\/bmjopen-2018-025396","volume":"9","author":"R O\u2019Connor","year":"2019","unstructured":"O\u2019Connor, R. et al. Medical management of acute upper respiratory infections in an urban primary care out-of-hours facility: cross-sectional study of patient presentations and expectations. BMJ Open 9, e025396 (2019).","journal-title":"BMJ Open"},{"key":"499_CR37","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.idc.2004.07.001","volume":"18","author":"E Aagaard","year":"2004","unstructured":"Aagaard, E. & Gonzales, R. Management of acute bronchitis in healthy adults. Infect Dis Clin North Am 18, 919\u2013937 (2004).","journal-title":"Infect Dis Clin North Am"},{"key":"499_CR38","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1080\/00325481.2020.1751497","volume":"132","author":"D Martin","year":"2020","unstructured":"Martin, D., Konrad, M., Adarkwah, C. C. & Kostev, K. Reduced antibiotic use after initial treatment of acute respiratory infections with phytopharmaceuticals- a retrospective cohort study. Postgrad Med 132, 412\u2013418 (2020).","journal-title":"Postgrad Med"},{"key":"499_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102613","volume":"55","author":"D Soilemezi","year":"2020","unstructured":"Soilemezi, D. et al. Herbal medicine for acute bronchitis: A qualitative interview study of patients\u2019 and health professionals\u2019 views. Complement Ther Med 55, 102613 (2020).","journal-title":"Complement Ther Med"},{"key":"499_CR40","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/fampra\/cmad084","volume":"40","author":"P Sebo","year":"2023","unstructured":"Sebo, P., Winkler, N. E., Moussa, M. A., Haller, D. M. & Maisonneuve, H. Nonpharmacological home remedies for upper respiratory tract infections: a cross-sectional study of primary care patients in Switzerland and France. Family Practice 40, 564\u2013568 (2023).","journal-title":"Family Practice"},{"key":"499_CR41","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/antibiotics13040364","volume":"13","author":"G Gancitano","year":"2024","unstructured":"Gancitano, G. et al. Echinacea reduces antibiotics by preventing respiratory infections: A meta-analysis (ERA-PRIMA). Antibiotics (Basel) 13, 364 (2024).","journal-title":"Antibiotics (Basel)"},{"key":"499_CR42","doi-asserted-by":"publisher","first-page":"e001336","DOI":"10.1136\/bmjmed-2025-001336","volume":"4","author":"N Isaac","year":"2025","unstructured":"Isaac, N. & Anthony, A. M. Detection bias and the role of negative control outcomes. BMJ Med 4, e001336 (2025).","journal-title":"BMJ Med"}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00499-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T22:51:06Z","timestamp":1782082266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00499-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1038\/s41533-026-00499-1","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"After a first complete draft was written by the authors, they used ChatGPT (version 5, OpenAI) to proofread parts of the manuscript in order to improve readability and language, as the authors are not native English speakers. The prompt used was \u2018optimise this text for a scientific publication without changing the content\u2019, and improved formulations were adopted where considered better. AI was not used for substantive content generation. After using this tool, the authors reviewed and edited the manuscript as needed and take full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"41"}}